<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" xmlns:podcast="https://podcastindex.org/namespace/1.0">
  <channel>
    <atom:link href="https://feeds.simplecast.com/DskUOSmn" rel="self" title="MP3 Audio" type="application/atom+xml"/>
    <atom:link href="https://simplecast.superfeedr.com" rel="hub" xmlns="http://www.w3.org/2005/Atom"/>
    <generator>https://simplecast.com</generator>
    <title>The Propel(x) Podcast</title>
    <description>Discussions on startups and investing.</description>
    <copyright>2021, The Propel(x) Podcast, Propel(x) Inc.</copyright>
    <language>en</language>
    <pubDate>Wed, 22 Oct 2025 18:01:25 +0000</pubDate>
    <lastBuildDate>Wed, 22 Oct 2025 18:01:36 +0000</lastBuildDate>
    <image>
      <link>https://podcast.propelx.com</link>
      <title>The Propel(x) Podcast</title>
      <url>https://image.simplecastcdn.com/images/66d4740c-3ff3-4111-bc8a-c7bce86a48ee/f1228a7d-0abb-4800-9870-7f2d21723aec/3000x3000/propelx.jpg?aid=rss_feed</url>
    </image>
    <link>https://podcast.propelx.com</link>
    <itunes:type>episodic</itunes:type>
    <itunes:summary>Discussions on startups and investing.</itunes:summary>
    <itunes:author>Swati Chaturvedi</itunes:author>
    <itunes:explicit>false</itunes:explicit>
    <itunes:image href="https://image.simplecastcdn.com/images/66d4740c-3ff3-4111-bc8a-c7bce86a48ee/f1228a7d-0abb-4800-9870-7f2d21723aec/3000x3000/propelx.jpg?aid=rss_feed"/>
    <itunes:new-feed-url>https://feeds.simplecast.com/DskUOSmn</itunes:new-feed-url>
    <itunes:keywords>angel investor, seed investing, angel investing, deep technology startups</itunes:keywords>
    <itunes:owner>
      <itunes:name>Propel(x) Inc.</itunes:name>
      <itunes:email>info@propelx.com</itunes:email>
    </itunes:owner>
    <itunes:category text="Business">
      <itunes:category text="Investing"/>
    </itunes:category>
    <itunes:category text="Education">
      <itunes:category text="How To"/>
    </itunes:category>
    <itunes:category text="Technology"/>
    <item>
      <guid isPermaLink="false">0bf83c5c-d61d-477d-8331-b36e5a3f1d3f</guid>
      <title>Data-Driven Healthcare Real Estate: Didier Choukroun on Building SPHERE Investments</title>
      <description><![CDATA[<p>Title: Building a Data-Driven Healthcare Real Estate Empire with Didier Choukroun</p><p>Guest: Didier Choukroun, Founder & CEO of SPHERE Healthcare Investments</p><p>Host: Swati Chaturvedi, CEO of Propel(x)</p><p>Episode Overview:<br />In this episode, Swati Chaturvedi talks with Didier Choukroun, the visionary behind SPHERE Healthcare Investments, a leading healthcare-focused real estate investment firm. Didier shares his journey from his early career in France and Latin America to establishing SPHERE in the U.S., expanding into Europe, and building a $1.3 billion portfolio across 15 U.S. states and several European countries.</p><p>Key Discussion Points:</p><ul><li>Didier’s career journey: From real estate development in France to entrepreneurship in Latin America and the U.S.</li><li>Founding SPHERE in 2010 with a mission to improve public health through healthcare real estate investment.</li></ul><p>SPHERE’s unique investment approach:</p><ul><li>Data-driven strategy: Using proprietary healthcare analytics for smarter decision-making.</li><li>Vertical integration: Managing every stage of the investment process in-house.</li><li>Multidisciplinary team: Physicians, public health experts, and data scientists working together to optimize investment outcomes.</li></ul><p>SPHERE’s portfolio highlights:</p><ul><li>39 assets across 15 U.S. states, plus France, Spain, Italy, and soon the UK.</li><li>Average IRR of 23.5% and annual cash yields above 10%.</li><li>Successful track record of 12 asset dispositions with exceptional returns.</li></ul><ul><li>The role of SPHERE’s proprietary data platform in mitigating risk and identifying opportunities.</li><li>The importance of building authentic relationships with healthcare operators.</li><li>Partnership with Propel(x) to make institutional-grade healthcare real estate opportunities accessible to accredited retail investors.</li><li>Didier’s insights on risk management, investment strategy, and leveraging data for long-term success in healthcare real estate.</li></ul><p>Why Listen:<br />This episode is packed with actionable insights for investors, healthcare professionals, and anyone curious about the intersection of real estate, data analytics, and public health. Didier’s story illustrates how strategic vision, data-driven decision-making, and operational expertise can create a resilient, high-performing investment firm.</p><p>Resources & Links:<br />SPHERE Investments<br />Propel(x)</p><p>Timestamps:<br />00:00 – Welcome & Introduction<br />00:45 – Overview of SPHERE Healthcare Investments<br />02:57 – SPHERE’s building blocks: data, team, vertical integration<br />04:27 – Portfolio size, assets, and track record<br />12:11 – Didier’s early career and entrepreneurial journey<br />19:40 – Early U.S. investments and lessons learned<br />27:24 – SPHERE’s current data-driven strategy<br />34:07 – Partnership with Propel(x)<br />40:35 – Final thoughts for the audience</p>
]]></description>
      <pubDate>Wed, 22 Oct 2025 18:01:25 +0000</pubDate>
      <author>info@propelx.com (Didier Choukroun, Swati Chaturvedi)</author>
      <link>https://podcast.propelx.com/episodes/data-driven-healthcare-real-estate-didier-choukroun-on-building-sphere-investments-bjwCqcX9</link>
      <media:thumbnail height="720" url="https://image.simplecastcdn.com/images/f5dca78c-eb9a-4556-b219-bcdb70231fda/277c5b78-e2c8-4c30-a2b8-041c3e1f0ac6/podcast-20thumbnailss.jpg" width="1280"/>
      <content:encoded><![CDATA[<p>Title: Building a Data-Driven Healthcare Real Estate Empire with Didier Choukroun</p><p>Guest: Didier Choukroun, Founder & CEO of SPHERE Healthcare Investments</p><p>Host: Swati Chaturvedi, CEO of Propel(x)</p><p>Episode Overview:<br />In this episode, Swati Chaturvedi talks with Didier Choukroun, the visionary behind SPHERE Healthcare Investments, a leading healthcare-focused real estate investment firm. Didier shares his journey from his early career in France and Latin America to establishing SPHERE in the U.S., expanding into Europe, and building a $1.3 billion portfolio across 15 U.S. states and several European countries.</p><p>Key Discussion Points:</p><ul><li>Didier’s career journey: From real estate development in France to entrepreneurship in Latin America and the U.S.</li><li>Founding SPHERE in 2010 with a mission to improve public health through healthcare real estate investment.</li></ul><p>SPHERE’s unique investment approach:</p><ul><li>Data-driven strategy: Using proprietary healthcare analytics for smarter decision-making.</li><li>Vertical integration: Managing every stage of the investment process in-house.</li><li>Multidisciplinary team: Physicians, public health experts, and data scientists working together to optimize investment outcomes.</li></ul><p>SPHERE’s portfolio highlights:</p><ul><li>39 assets across 15 U.S. states, plus France, Spain, Italy, and soon the UK.</li><li>Average IRR of 23.5% and annual cash yields above 10%.</li><li>Successful track record of 12 asset dispositions with exceptional returns.</li></ul><ul><li>The role of SPHERE’s proprietary data platform in mitigating risk and identifying opportunities.</li><li>The importance of building authentic relationships with healthcare operators.</li><li>Partnership with Propel(x) to make institutional-grade healthcare real estate opportunities accessible to accredited retail investors.</li><li>Didier’s insights on risk management, investment strategy, and leveraging data for long-term success in healthcare real estate.</li></ul><p>Why Listen:<br />This episode is packed with actionable insights for investors, healthcare professionals, and anyone curious about the intersection of real estate, data analytics, and public health. Didier’s story illustrates how strategic vision, data-driven decision-making, and operational expertise can create a resilient, high-performing investment firm.</p><p>Resources & Links:<br />SPHERE Investments<br />Propel(x)</p><p>Timestamps:<br />00:00 – Welcome & Introduction<br />00:45 – Overview of SPHERE Healthcare Investments<br />02:57 – SPHERE’s building blocks: data, team, vertical integration<br />04:27 – Portfolio size, assets, and track record<br />12:11 – Didier’s early career and entrepreneurial journey<br />19:40 – Early U.S. investments and lessons learned<br />27:24 – SPHERE’s current data-driven strategy<br />34:07 – Partnership with Propel(x)<br />40:35 – Final thoughts for the audience</p>
]]></content:encoded>
      <enclosure length="37078456" type="audio/mpeg" url="https://cdn.simplecast.com/audio/1698c82a-df63-4b69-bd2d-2b9efbf035e7/episodes/eaec9961-67f4-4194-b758-d6770b16989e/audio/94c894b4-05a3-4f6e-83e1-b4cb3951118b/default_tc.mp3?aid=rss_feed&amp;feed=DskUOSmn"/>
      <itunes:title>Data-Driven Healthcare Real Estate: Didier Choukroun on Building SPHERE Investments</itunes:title>
      <itunes:author>Didier Choukroun, Swati Chaturvedi</itunes:author>
      <itunes:image href="https://image.simplecastcdn.com/images/f5dca78c-eb9a-4556-b219-bcdb70231fda/1f84a096-e04d-4d68-b732-2eeb584212e4/3000x3000/podcast-20thumbnailss-20for-20simplecast-20-3000-20x-203000-20px.jpg?aid=rss_feed"/>
      <itunes:duration>00:38:37</itunes:duration>
      <itunes:summary>In this episode, Swati Chaturvedi sits down with Didier Choukroun, founder and CEO of SPHERE Healthcare Investments, to explore the journey of building a data-driven healthcare real estate empire. Didier shares his remarkable path from starting in France, expanding into Latin America, and eventually establishing a multi-billion-dollar portfolio across the U.S. and Europe.

Listeners will learn about SPHERE’s unique approach to healthcare investments, including their focus on data analytics, vertical integration, and partnerships with healthcare operators. Didier explains how the firm delivers high IRRs and consistent cash yields by combining market insight, operational expertise, and a disciplined investment strategy.

The episode also highlights SPHERE’s recent partnership with Propel(x), aimed at making institutional-level healthcare real estate opportunities accessible to accredited retail investors. Didier shares insights into the evolving healthcare investment landscape and offers advice on risk management, strategic growth, and leveraging data for smarter decision-making.

This conversation is a must-listen for sophisticated investors, healthcare professionals, and anyone interested in the intersection of real estate, data, and public health.</itunes:summary>
      <itunes:subtitle>In this episode, Swati Chaturvedi sits down with Didier Choukroun, founder and CEO of SPHERE Healthcare Investments, to explore the journey of building a data-driven healthcare real estate empire. Didier shares his remarkable path from starting in France, expanding into Latin America, and eventually establishing a multi-billion-dollar portfolio across the U.S. and Europe.

Listeners will learn about SPHERE’s unique approach to healthcare investments, including their focus on data analytics, vertical integration, and partnerships with healthcare operators. Didier explains how the firm delivers high IRRs and consistent cash yields by combining market insight, operational expertise, and a disciplined investment strategy.

The episode also highlights SPHERE’s recent partnership with Propel(x), aimed at making institutional-level healthcare real estate opportunities accessible to accredited retail investors. Didier shares insights into the evolving healthcare investment landscape and offers advice on risk management, strategic growth, and leveraging data for smarter decision-making.

This conversation is a must-listen for sophisticated investors, healthcare professionals, and anyone interested in the intersection of real estate, data, and public health.</itunes:subtitle>
      <itunes:keywords>investing, healthcarerealestate, realestateinvestment, privatemarkets, alternativeinvestments, innovation, podcast, propelx, partnership, leadership</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>14</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4c5b2a93-c1d1-4140-aacc-4cf29890d57f</guid>
      <title>Non-Dilutive Funding for Deeptech Startups: How the National Science Foundation Invests</title>
      <description><![CDATA[<p>Discussion Points</p><ul><li>(4:12) What does the NSF look for in companies?</li><li>(6:05) How does the selection process work?</li><li>(10:05) What are the non-technical elements of the awards program?</li><li>(19:12) Examples of breakout success in the NSF portfolio</li><li>(21:14) What distinguishes a novel technology from a promising technology based startup?</li><li>(24:45) NSF's outreach efforts for diversity and inclusion</li><li>(29:16) Why should the government finance technology risk?</li></ul><p>References</p><ul><li><a href="https://seedfund.nsf.gov/">National Science Foundation</a></li><li><a href="https://en.wikipedia.org/wiki/Bayh%E2%80%93Dole_Act#:~:text=The%20Bayh%E2%80%93Dole%20Act%20or,from%20federal%20government%2Dfunded%20research.">Bayh-Dole Act 1980 (Wikipedia)</a></li><li><a href="https://www.ginkgobioworks.com/">Ginko Bioworks</a></li><li><a href="https://www.opus-12.com/">Opus 12</a></li><li><a href="https://www.marinusanalytics.com/">Marinus Analytics</a></li></ul><p>Topics</p><ul><li>Grant funding for science startups</li><li>Startup investing</li><li>Commercialization</li><li>Investing diligence</li><li>Evaluating team</li></ul><p>Get to know Propel(x)</p><ul><li><a href="https://twitter.com/propel_x">Propel(x) Twitter</a></li><li><a href="https://www.linkedin.com/company/propel-x-/">Propel(x) LinkedIn</a></li><li><a href="https://www.propelx.com/for_investors/">Join Propel(x) as an Accredited Investor</a></li><li><a href="https://www.linkedin.com/in/andersonreed">Andy Reed</a></li></ul>
]]></description>
      <pubDate>Fri, 22 Jan 2021 01:00:00 +0000</pubDate>
      <author>info@propelx.com (Ben Schrag, Andy Reed)</author>
      <link>https://podcast.propelx.com/episodes/benschrag-woB0BPJG</link>
      <content:encoded><![CDATA[<p>Discussion Points</p><ul><li>(4:12) What does the NSF look for in companies?</li><li>(6:05) How does the selection process work?</li><li>(10:05) What are the non-technical elements of the awards program?</li><li>(19:12) Examples of breakout success in the NSF portfolio</li><li>(21:14) What distinguishes a novel technology from a promising technology based startup?</li><li>(24:45) NSF's outreach efforts for diversity and inclusion</li><li>(29:16) Why should the government finance technology risk?</li></ul><p>References</p><ul><li><a href="https://seedfund.nsf.gov/">National Science Foundation</a></li><li><a href="https://en.wikipedia.org/wiki/Bayh%E2%80%93Dole_Act#:~:text=The%20Bayh%E2%80%93Dole%20Act%20or,from%20federal%20government%2Dfunded%20research.">Bayh-Dole Act 1980 (Wikipedia)</a></li><li><a href="https://www.ginkgobioworks.com/">Ginko Bioworks</a></li><li><a href="https://www.opus-12.com/">Opus 12</a></li><li><a href="https://www.marinusanalytics.com/">Marinus Analytics</a></li></ul><p>Topics</p><ul><li>Grant funding for science startups</li><li>Startup investing</li><li>Commercialization</li><li>Investing diligence</li><li>Evaluating team</li></ul><p>Get to know Propel(x)</p><ul><li><a href="https://twitter.com/propel_x">Propel(x) Twitter</a></li><li><a href="https://www.linkedin.com/company/propel-x-/">Propel(x) LinkedIn</a></li><li><a href="https://www.propelx.com/for_investors/">Join Propel(x) as an Accredited Investor</a></li><li><a href="https://www.linkedin.com/in/andersonreed">Andy Reed</a></li></ul>
]]></content:encoded>
      <enclosure length="33114532" type="audio/mpeg" url="https://cdn.simplecast.com/audio/1698c82a-df63-4b69-bd2d-2b9efbf035e7/episodes/f2cbe737-8c66-4157-9eaa-cfa35a774a16/audio/1c6013bc-ef74-4f7b-b31f-af7b85326662/default_tc.mp3?aid=rss_feed&amp;feed=DskUOSmn"/>
      <itunes:title>Non-Dilutive Funding for Deeptech Startups: How the National Science Foundation Invests</itunes:title>
      <itunes:author>Ben Schrag, Andy Reed</itunes:author>
      <itunes:image href="https://image.simplecastcdn.com/images/f5dca78c-eb9a-4556-b219-bcdb70231fda/fb68dd24-3880-45ec-b8c1-2eebe25b036f/3000x3000/ep-13-podcast-1080x1080.jpg?aid=rss_feed"/>
      <itunes:duration>00:34:30</itunes:duration>
      <itunes:summary>Every year the National Science Foundation (NSF) invests over $200 million to help launch hard-tech startups. The government agency is often the &quot;first money in.&quot; With a deep bench of academics and researchers to aid their evaluation, the NSF is able to evaluate cutting edge technologies to promote and support. 

This episode features Ben Schrag, Senior Program Director for the SBIR/STTR programs. We discuss how the NSF looks for technology risk, and what steps the agency takes in supporting early commercialization for deeptech startups.

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. This is for informational purposes only. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.  </itunes:summary>
      <itunes:subtitle>Every year the National Science Foundation (NSF) invests over $200 million to help launch hard-tech startups. The government agency is often the &quot;first money in.&quot; With a deep bench of academics and researchers to aid their evaluation, the NSF is able to evaluate cutting edge technologies to promote and support. 

This episode features Ben Schrag, Senior Program Director for the SBIR/STTR programs. We discuss how the NSF looks for technology risk, and what steps the agency takes in supporting early commercialization for deeptech startups.

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. This is for informational purposes only. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.  </itunes:subtitle>
      <itunes:keywords>seed funding, investing, angel investing, grant funding, science, venture capital, startups</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>13</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">940ac1db-c276-493a-b3d4-d1a9444c7687</guid>
      <title>Strategies for Deep Tech Investing with Eric Rosenblum from Tsingyuan Ventures</title>
      <description><![CDATA[<p><strong>Discussion points</strong></p><ul><li>(2:43) What is Deep Tech?</li><li>(6:26) How do you gauge commercial readiness for Deep Tech?</li><li>(8:51) How do you evaluate the unique risk factors of Deep Tech startups?</li><li>(13:42) How does alignment and investment strategy create value as a venture investor?</li><li>(18:35) Bridging the technical founder to successful commercial founder gap.</li><li>(25:20) What areas of deep tech will be the biggest drivers of innovation and growth in the next investment period?</li></ul><p><strong>References</strong></p><ul><li><a href="http://www.tsingyuan.ventures/">Tsingyuan Ventures</a></li><li><a href="http://www.teec-angel.com/wp2014/home/">TEEC Angels</a></li><li><a href="https://www.tsinghua.edu.cn/en/index.htm">Tsingyua University</a></li><li><a href="http://zoom.com/">Zoom</a></li><li><a href="https://www.ginkgobioworks.com/">Ginko Bioworks</a></li><li><a href="https://en.wikipedia.org/wiki/Synthetic_biology">Synthetic biology</a> (Wikipedia)</li><li><a href="https://www.ambilightinc.com/">Ambilight</a> smart glass</li><li><a href="https://missionbio.com/">Mission Bio</a></li><li><a href="https://www.weride.ai/">WeRide</a></li><li><a href="https://plus.ai/">Plus.ai</a></li><li><a href="https://www.appliedmaterials.com/company/applied-ventures">Applied Ventures</a></li><li><a href="https://www.tdk-ventures.com/">TDK Ventures</a></li><li><a href="https://xmems.com/">xMems</a> microspeakers</li><li><a href="https://subtlemedical.com/">Subtle Medical</a></li></ul><p><strong>Topics</strong></p><ul><li>Deep Tech (deeptech) startups</li><li>Artificial intelligence</li><li>Synthetic biology</li><li>Genetics</li><li>Autonomous driving</li><li>Venture Capital Investing</li><li>Investing Strategy</li><li>Technical risk & due diligence</li></ul><p>Get to know Propel(x)</p><ul><li><a href="https://twitter.com/propel_x">Propel(x) Twitter</a></li><li><a href="https://www.linkedin.com/company/propel-x-/">Propel(x) LinkedIn</a></li><li><a href="https://www.propelx.com/for_investors/">Join Propel(x) as an Accredited Investor</a></li><li><a href="https://www.linkedin.com/in/andersonreed">Andy Reed</a></li></ul>
]]></description>
      <pubDate>Thu, 10 Dec 2020 21:18:20 +0000</pubDate>
      <author>info@propelx.com (Andy Reed, Eric Rosenblum)</author>
      <link>https://podcast.propelx.com/episodes/ericrosenblum-zpbOHI9A</link>
      <content:encoded><![CDATA[<p><strong>Discussion points</strong></p><ul><li>(2:43) What is Deep Tech?</li><li>(6:26) How do you gauge commercial readiness for Deep Tech?</li><li>(8:51) How do you evaluate the unique risk factors of Deep Tech startups?</li><li>(13:42) How does alignment and investment strategy create value as a venture investor?</li><li>(18:35) Bridging the technical founder to successful commercial founder gap.</li><li>(25:20) What areas of deep tech will be the biggest drivers of innovation and growth in the next investment period?</li></ul><p><strong>References</strong></p><ul><li><a href="http://www.tsingyuan.ventures/">Tsingyuan Ventures</a></li><li><a href="http://www.teec-angel.com/wp2014/home/">TEEC Angels</a></li><li><a href="https://www.tsinghua.edu.cn/en/index.htm">Tsingyua University</a></li><li><a href="http://zoom.com/">Zoom</a></li><li><a href="https://www.ginkgobioworks.com/">Ginko Bioworks</a></li><li><a href="https://en.wikipedia.org/wiki/Synthetic_biology">Synthetic biology</a> (Wikipedia)</li><li><a href="https://www.ambilightinc.com/">Ambilight</a> smart glass</li><li><a href="https://missionbio.com/">Mission Bio</a></li><li><a href="https://www.weride.ai/">WeRide</a></li><li><a href="https://plus.ai/">Plus.ai</a></li><li><a href="https://www.appliedmaterials.com/company/applied-ventures">Applied Ventures</a></li><li><a href="https://www.tdk-ventures.com/">TDK Ventures</a></li><li><a href="https://xmems.com/">xMems</a> microspeakers</li><li><a href="https://subtlemedical.com/">Subtle Medical</a></li></ul><p><strong>Topics</strong></p><ul><li>Deep Tech (deeptech) startups</li><li>Artificial intelligence</li><li>Synthetic biology</li><li>Genetics</li><li>Autonomous driving</li><li>Venture Capital Investing</li><li>Investing Strategy</li><li>Technical risk & due diligence</li></ul><p>Get to know Propel(x)</p><ul><li><a href="https://twitter.com/propel_x">Propel(x) Twitter</a></li><li><a href="https://www.linkedin.com/company/propel-x-/">Propel(x) LinkedIn</a></li><li><a href="https://www.propelx.com/for_investors/">Join Propel(x) as an Accredited Investor</a></li><li><a href="https://www.linkedin.com/in/andersonreed">Andy Reed</a></li></ul>
]]></content:encoded>
      <enclosure length="27772177" type="audio/mpeg" url="https://cdn.simplecast.com/audio/1698c82a-df63-4b69-bd2d-2b9efbf035e7/episodes/26f4142a-5832-4c1e-8e15-bd39fba0eb77/audio/9163561e-279a-4d70-9338-04a52396f8f4/default_tc.mp3?aid=rss_feed&amp;feed=DskUOSmn"/>
      <itunes:title>Strategies for Deep Tech Investing with Eric Rosenblum from Tsingyuan Ventures</itunes:title>
      <itunes:author>Andy Reed, Eric Rosenblum</itunes:author>
      <itunes:image href="https://image.simplecastcdn.com/images/66d4740c-3ff3-4111-bc8a-c7bce86a48ee/6a6f28c3-8acf-4430-838b-7f7e20504516/3000x3000/ep-12-podcast-1080x1080.jpg?aid=rss_feed"/>
      <itunes:duration>00:28:56</itunes:duration>
      <itunes:summary>In this episode we speak with Eric Rosenblum on how to think about strategies for deep tech investing. Tsingyuan Ventures is the successor fund to the TEEC Angels, a Silicon Valley angel group of graduates of China&apos;s Tsingyua Univeristy (China&apos;s most elite school). The TEEC Angels were early investors in Zoom (NASDAQ: ZM), Ginko BioWorks, and others. 

Tsingyuan Ventures is a $100M USD fund investing in disciplinary technology across enterprise, life sciences, and deep tech. Notable investments include WeRide, a leading autonomous vehicle technology startup in China, Otter.AI, an artificial intelligence live voice transcription company, the precision medicine company Mission Bio, and the no-code platform, Bubble. 

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. This is for informational purposes only. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments. </itunes:summary>
      <itunes:subtitle>In this episode we speak with Eric Rosenblum on how to think about strategies for deep tech investing. Tsingyuan Ventures is the successor fund to the TEEC Angels, a Silicon Valley angel group of graduates of China&apos;s Tsingyua Univeristy (China&apos;s most elite school). The TEEC Angels were early investors in Zoom (NASDAQ: ZM), Ginko BioWorks, and others. 

Tsingyuan Ventures is a $100M USD fund investing in disciplinary technology across enterprise, life sciences, and deep tech. Notable investments include WeRide, a leading autonomous vehicle technology startup in China, Otter.AI, an artificial intelligence live voice transcription company, the precision medicine company Mission Bio, and the no-code platform, Bubble. 

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. This is for informational purposes only. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments. </itunes:subtitle>
      <itunes:keywords>investing, angel investing, deal sourcing, startup investing, autonomous driving, artificial intelligence, investing in startups, synthetic biology, networks, evaluating risks, vc, entrepreneurship, venture capital, investment strategy, technical founders, electrification, due diligence</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>12</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">fb54ba28-1c28-4fe1-a3c1-0eb29775df45</guid>
      <title>Deal Sourcing and Climate Tech with Jason Holt of Baruch Future Ventures</title>
      <description><![CDATA[<p>Discussion Points</p><ul><li>(0:30) What is product-go-to-market fit?</li><li>(3:00) Why isn't Climate Tech just Cleantech 2.0?</li><li>(8:00) How do you source good deals efficiently?</li><li>(17:00) Who else supports Climate Tech?</li><li>(23:31) What lessons did you learn from your first successful investment that are still relevant today?<br /> </li></ul><p>References</p><ul><li><a href="https://www.baruch.vc/">Baruch Future Ventures</a></li><li><a href="https://www.baruch.vc/jason-holt">Jason Holt</a></li><li><a href="https://www.baruch.vc/tom-baruch">Tom Baruch</a></li><li><a href="https://geltor.com/">Geltor</a></li><li><a href="https://www.cyclotronroad.org/">Cyclotron Road</a></li><li><a href="https://www.engine.xyz/">MIT Engine</a></li><li><a href="https://www.breakthroughenergy.org/">Breakthrough Energy Ventures</a></li><li><a href="https://www.newenergynexus.com/">New Energy Nexus</a></li><li><a href="https://www.lbl.gov/about/">Lawrence Berkeley National Labs</a></li><li><a href="https://www.energy.gov/">US Department of Energy</a></li><li><a href="https://www.nsf.gov/news/special_reports/i-corps/">National Science Foundation Innovation Corps</a> (ICORPS)</li><li><a href="http://www.m34capital.com/">M34 Capital</a></li><li><a href="https://www.maxygen.com/">Maxygen</a></li><li><a href="http://fhalab.caltech.edu/">Frances H. Arnold Group at Caltech</a></li><li><a href="https://www.kauffman.org/">Kauffman Foundation</a></li></ul><p><br />Topics</p><ul><li>Investment Diligence</li><li>Hard Tech</li><li>Tough Tech</li><li>Carbon Tech</li><li>Decarbonization</li><li>Technology commercialization</li><li>Cleantech</li><li>Synthetic Biology</li><li>Product Market Fit</li><li>Electrification</li><li>Sustainable Protiens</li><li>Pivots</li><li>Climate Catastrophe</li><li>Wildfires</li><li>Climate Change</li><li>Hope</li><li>Solar and Wind Energy</li><li>Geothermal</li></ul><p> </p><p>Get to know Propel(x)</p><ul><li><a href="https://twitter.com/propel_x">Propel(x) Twitter</a></li><li><a href="https://www.linkedin.com/company/propel-x-/">Propel(x) LinkedIn</a></li><li><a href="https://www.propelx.com/for_investors/">Join Propel(x) as an Accredited Investor</a></li><li><a href="https://www.linkedin.com/in/andersonreed">Andy Reed</a></li></ul>
]]></description>
      <pubDate>Thu, 12 Nov 2020 18:52:19 +0000</pubDate>
      <author>info@propelx.com (Jason Holt, Andy Reed)</author>
      <link>https://podcast.propelx.com/episodes/jasonholt-6w0XLqXq</link>
      <content:encoded><![CDATA[<p>Discussion Points</p><ul><li>(0:30) What is product-go-to-market fit?</li><li>(3:00) Why isn't Climate Tech just Cleantech 2.0?</li><li>(8:00) How do you source good deals efficiently?</li><li>(17:00) Who else supports Climate Tech?</li><li>(23:31) What lessons did you learn from your first successful investment that are still relevant today?<br /> </li></ul><p>References</p><ul><li><a href="https://www.baruch.vc/">Baruch Future Ventures</a></li><li><a href="https://www.baruch.vc/jason-holt">Jason Holt</a></li><li><a href="https://www.baruch.vc/tom-baruch">Tom Baruch</a></li><li><a href="https://geltor.com/">Geltor</a></li><li><a href="https://www.cyclotronroad.org/">Cyclotron Road</a></li><li><a href="https://www.engine.xyz/">MIT Engine</a></li><li><a href="https://www.breakthroughenergy.org/">Breakthrough Energy Ventures</a></li><li><a href="https://www.newenergynexus.com/">New Energy Nexus</a></li><li><a href="https://www.lbl.gov/about/">Lawrence Berkeley National Labs</a></li><li><a href="https://www.energy.gov/">US Department of Energy</a></li><li><a href="https://www.nsf.gov/news/special_reports/i-corps/">National Science Foundation Innovation Corps</a> (ICORPS)</li><li><a href="http://www.m34capital.com/">M34 Capital</a></li><li><a href="https://www.maxygen.com/">Maxygen</a></li><li><a href="http://fhalab.caltech.edu/">Frances H. Arnold Group at Caltech</a></li><li><a href="https://www.kauffman.org/">Kauffman Foundation</a></li></ul><p><br />Topics</p><ul><li>Investment Diligence</li><li>Hard Tech</li><li>Tough Tech</li><li>Carbon Tech</li><li>Decarbonization</li><li>Technology commercialization</li><li>Cleantech</li><li>Synthetic Biology</li><li>Product Market Fit</li><li>Electrification</li><li>Sustainable Protiens</li><li>Pivots</li><li>Climate Catastrophe</li><li>Wildfires</li><li>Climate Change</li><li>Hope</li><li>Solar and Wind Energy</li><li>Geothermal</li></ul><p> </p><p>Get to know Propel(x)</p><ul><li><a href="https://twitter.com/propel_x">Propel(x) Twitter</a></li><li><a href="https://www.linkedin.com/company/propel-x-/">Propel(x) LinkedIn</a></li><li><a href="https://www.propelx.com/for_investors/">Join Propel(x) as an Accredited Investor</a></li><li><a href="https://www.linkedin.com/in/andersonreed">Andy Reed</a></li></ul>
]]></content:encoded>
      <enclosure length="29467002" type="audio/mpeg" url="https://cdn.simplecast.com/audio/1698c82a-df63-4b69-bd2d-2b9efbf035e7/episodes/4dddd168-ca83-40a3-bc65-ce60898637c6/audio/4940a5a5-24d9-4c5f-8405-2ad045492e62/default_tc.mp3?aid=rss_feed&amp;feed=DskUOSmn"/>
      <itunes:title>Deal Sourcing and Climate Tech with Jason Holt of Baruch Future Ventures</itunes:title>
      <itunes:author>Jason Holt, Andy Reed</itunes:author>
      <itunes:image href="https://image.simplecastcdn.com/images/66d4740c-3ff3-4111-bc8a-c7bce86a48ee/37618452-f07c-47e4-9e6d-8ac1bc9faef3/3000x3000/ep-11-podcast-1080x1080.jpg?aid=rss_feed"/>
      <itunes:duration>00:30:42</itunes:duration>
      <itunes:summary>In this episode we hear from Jason Holt on how to build a quality efficient deal sourcing practice. He shares his perspective on how to distinguish good markets from bad markets, and what to look for in founders as an investor. 

Jason&apos;s previous experience as a deep tech entrepreneur and current climate tech investor contributes to his views on how climate tech investing gives him hope in an era of climate catastrophe.

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. This is for informational purposes only. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.</itunes:summary>
      <itunes:subtitle>In this episode we hear from Jason Holt on how to build a quality efficient deal sourcing practice. He shares his perspective on how to distinguish good markets from bad markets, and what to look for in founders as an investor. 

Jason&apos;s previous experience as a deep tech entrepreneur and current climate tech investor contributes to his views on how climate tech investing gives him hope in an era of climate catastrophe.

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. This is for informational purposes only. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.</itunes:subtitle>
      <itunes:keywords>cleantech, investing, angel investing, deal sourcing, startup strategy, vc, family office investing, venture capital, go to market strategy, climate tech</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>11</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">33114aea-fa3b-45e6-9b16-c2570d2deb97</guid>
      <title>Due-Diligence - How to Evaluate Technology, Regulatory and IP Risks</title>
      <description><![CDATA[In this episode we begin to analyze the Internal Risks of a company - Technology, Regulatory and IP risks are covered in this episode. Join us as we define each of the risks, and discuss the key considerations for each. 

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments. 
]]></description>
      <pubDate>Thu, 18 Jun 2020 01:07:19 +0000</pubDate>
      <author>info@propelx.com (Swati Chaturvedi, Andy Reed)</author>
      <link>https://podcast.propelx.com/episodes/due-diligence-how-to-evaluate-technology-regulatory-and-ip-risks-s36oiejG</link>
      <enclosure length="29461401" type="audio/mpeg" url="https://cdn.simplecast.com/audio/1698c8/1698c82a-df63-4b69-bd2d-2b9efbf035e7/d6d8e70c-8e64-4048-8035-29cd39db1902/episode-10-final_tc.mp3?aid=rss_feed&amp;feed=DskUOSmn"/>
      <itunes:title>Due-Diligence - How to Evaluate Technology, Regulatory and IP Risks</itunes:title>
      <itunes:author>Swati Chaturvedi, Andy Reed</itunes:author>
      <itunes:duration>00:30:42</itunes:duration>
      <itunes:summary>In this episode we begin to analyze the Internal Risks of a company - Technology, Regulatory and IP risks are covered in this episode. Join us as we define each of the risks, and discuss the key considerations for each. 

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.</itunes:summary>
      <itunes:subtitle>In this episode we begin to analyze the Internal Risks of a company - Technology, Regulatory and IP risks are covered in this episode. Join us as we define each of the risks, and discuss the key considerations for each. 

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.</itunes:subtitle>
      <itunes:keywords>angel investing, equity crowdfunding, regulatory risks, venture capital, ip, angel investors, technology risk, due diligence</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>10</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d443e79b-3c8d-4ec8-9844-ef641c77166f</guid>
      <title>Due-Diligence: How to Evaluate Competition</title>
      <description><![CDATA[In Episode 4 we had put out a framework for 'How to Evaluate a Startup'. Episodes 6 and 7 discussed 'How to Evaluate the Market' and 'How to Evaluate the Team', respectively. In this episode, we continue the discussion on how to evaluate a startup. Today we discuss how to evaluate competition. 

Highlights of this episode:
- Status quo, or how customers currently solve their problem, is always a competitor (often the main competitor)
- Good competitors improve one of three things for their customers: 1) they are lower cost 2) they are higher performance or 3) they are more convenient. 
- Talking to customers or industry experts is one of the best ways to learn about competition. 

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.
 
]]></description>
      <pubDate>Fri, 12 Jun 2020 23:30:51 +0000</pubDate>
      <author>info@propelx.com (Propel(x) Inc.)</author>
      <link>https://podcast.propelx.com/episodes/due-diligence-how-to-evaluate-competition-snMRhLJr</link>
      <enclosure length="12901190" type="audio/mpeg" url="https://cdn.simplecast.com/audio/1698c8/1698c82a-df63-4b69-bd2d-2b9efbf035e7/da1d72ac-84f6-4ee6-9ea0-20a0e923f02b/episode-9_tc.mp3?aid=rss_feed&amp;feed=DskUOSmn"/>
      <itunes:title>Due-Diligence: How to Evaluate Competition</itunes:title>
      <itunes:author>Propel(x) Inc.</itunes:author>
      <itunes:duration>00:13:27</itunes:duration>
      <itunes:summary>In Episode 4 we had put out a framework for &apos;How to Evaluate a Startup&apos;. Episodes 6 and 7 discussed &apos;How to Evaluate the Market&apos; and &apos;How to Evaluate the Team&apos;, respectively. In this episode, we continue the discussion on how to evaluate a startup. Today we discuss how to evaluate competition. 

Highlights of this episode:
- Status quo, or how customers currently solve their problem, is always a competitor (often the main competitor)
- Good competitors improve one of three things for their customers: 1) they are lower cost 2) they are higher performance or 3) they are more convenient. 
- Talking to customers or industry experts is one of the best ways to learn about competition. 

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.
</itunes:summary>
      <itunes:subtitle>In Episode 4 we had put out a framework for &apos;How to Evaluate a Startup&apos;. Episodes 6 and 7 discussed &apos;How to Evaluate the Market&apos; and &apos;How to Evaluate the Team&apos;, respectively. In this episode, we continue the discussion on how to evaluate a startup. Today we discuss how to evaluate competition. 

Highlights of this episode:
- Status quo, or how customers currently solve their problem, is always a competitor (often the main competitor)
- Good competitors improve one of three things for their customers: 1) they are lower cost 2) they are higher performance or 3) they are more convenient. 
- Talking to customers or industry experts is one of the best ways to learn about competition. 

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.
</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>9</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">81b876e1-148e-428d-87e5-24833a7e4073</guid>
      <title>The Process of Investing with Gopi Rangan</title>
      <description><![CDATA[Join us as Swati discusses the process of investing with Gopi Rangan, an experienced investor in the insurance technology sector. We discuss the explosion of Micro VCs in recent times. Additionally, Gopi shares his process, how he sources companies, how he interacts with them, what characteristics he specifically looks for and he manages his portfolio post investment. As an early stage investor, Gopi seeks to understand how he can help the company grow and thrive. 

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments. 
]]></description>
      <pubDate>Thu, 4 Jun 2020 20:35:04 +0000</pubDate>
      <author>info@propelx.com (Gopi Rangan, Swati Chaturvedi)</author>
      <link>https://podcast.propelx.com/episodes/the-process-of-investing-with-gopi-rangan-E4peYv1Y</link>
      <enclosure length="25898884" type="audio/mpeg" url="https://cdn.simplecast.com/audio/1698c8/1698c82a-df63-4b69-bd2d-2b9efbf035e7/f8f67004-5b6e-4525-9ae6-13ed50998112/episode-8-fin_tc.mp3?aid=rss_feed&amp;feed=DskUOSmn"/>
      <itunes:title>The Process of Investing with Gopi Rangan</itunes:title>
      <itunes:author>Gopi Rangan, Swati Chaturvedi</itunes:author>
      <itunes:image href="https://image.simplecastcdn.com/images/66d4740c-3ff3-4111-bc8a-c7bce86a48ee/379d7c1e-3a73-4f6b-b725-c24de06e66e0/3000x3000/ep-8-podcast-1080x1080.jpg?aid=rss_feed"/>
      <itunes:duration>00:26:59</itunes:duration>
      <itunes:summary>Join us as Swati discusses the process of investing with Gopi Rangan, an experienced investor in the insurance technology sector. We discuss the explosion of Micro VCs in recent times. Additionally, Gopi shares his process, how he sources companies, how he interacts with them, what characteristics he specifically looks for and he manages his portfolio post investment. As an early stage investor, Gopi seeks to understand how he can help the company grow and thrive. 

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.</itunes:summary>
      <itunes:subtitle>Join us as Swati discusses the process of investing with Gopi Rangan, an experienced investor in the insurance technology sector. We discuss the explosion of Micro VCs in recent times. Additionally, Gopi shares his process, how he sources companies, how he interacts with them, what characteristics he specifically looks for and he manages his portfolio post investment. As an early stage investor, Gopi seeks to understand how he can help the company grow and thrive. 

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.</itunes:subtitle>
      <itunes:keywords>early stage, saas, angel investing, seed investments, insurtech, crowdfunding, venture capital, fintech</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>8</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b8ae12b0-f1b5-4579-8b48-a45de8d9e2d6</guid>
      <title>Evaluating the Team as an Early Stage Investor</title>
      <description><![CDATA[Professional investors cite 'team' as the single most important criterion that influences the investment decision. Yet, there are no precise metrics that guide the evaluation of the team. The assessment is often fuzzy, vague, and based on how the investor 'feels' about the team. This episode presents three tips that early stage investors should keep in mind when evaluating team:
1. Early stage investing is subject to behavioral bias. Be aware of your biases.
2. Separate fact from opinion and focus on the facts when evaluating team.
3. Ask questions to cross check facts. E.g., who is really on the payroll vs. an advisor at large.

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments. 
]]></description>
      <pubDate>Tue, 19 May 2020 22:56:46 +0000</pubDate>
      <author>info@propelx.com (Swati Chaturvedi, Anderson Reed)</author>
      <link>https://podcast.propelx.com/episodes/evaluating-the-team-as-an-early-stage-investor-9UeEThI_</link>
      <enclosure length="11176272" type="audio/mpeg" url="https://cdn.simplecast.com/audio/1698c8/1698c82a-df63-4b69-bd2d-2b9efbf035e7/9e0d5a25-0bd4-46f5-bfbd-707174dcc0da/episode-7-edited-5-19-20-3-30-pm_tc.mp3?aid=rss_feed&amp;feed=DskUOSmn"/>
      <itunes:title>Evaluating the Team as an Early Stage Investor</itunes:title>
      <itunes:author>Swati Chaturvedi, Anderson Reed</itunes:author>
      <itunes:duration>00:11:39</itunes:duration>
      <itunes:summary>Professional investors cite &apos;team&apos; as the single most important criterion that influences the investment decision. Yet, there are no precise metrics that guide the evaluation of the team. The assessment is often fuzzy, vague, and based on how the investor &apos;feels&apos; about the team. This episode presents three tips that early stage investors should keep in mind when evaluating team:
1. Early stage investing is subject to behavioral bias. Be aware of your biases.
2. Separate fact from opinion and focus on the facts when evaluating team.
3. Ask questions to cross check facts. E.g., who is really on the payroll vs. an advisor at large.

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.</itunes:summary>
      <itunes:subtitle>Professional investors cite &apos;team&apos; as the single most important criterion that influences the investment decision. Yet, there are no precise metrics that guide the evaluation of the team. The assessment is often fuzzy, vague, and based on how the investor &apos;feels&apos; about the team. This episode presents three tips that early stage investors should keep in mind when evaluating team:
1. Early stage investing is subject to behavioral bias. Be aware of your biases.
2. Separate fact from opinion and focus on the facts when evaluating team.
3. Ask questions to cross check facts. E.g., who is really on the payroll vs. an advisor at large.

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.</itunes:subtitle>
      <itunes:keywords>angel investing, startup investing, equity crowdfunding, venture capital, angel investor, startups, due diligence</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>7</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">95f01a7f-8549-4021-b89f-471e1b9a7a77</guid>
      <title>How to Evaluate the Market for a Startup</title>
      <description><![CDATA[In Episode 4 we presented a framework to Evaluate startups. The framework lays out several criteria along which you may evaluate startups. Market size is one of those criteria. 

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.

In this Episode,  Andy and Swati discuss how to understand the Market for a startup. Questions we discuss are:  Why is an understanding of market potential relevant (and what is market potential anyway)? How should one estimate the market size? Does every startup really have to have a humungous market running into many billions of dollars? 

Join us as we discuss these topics and more, that surround the key elements of startup evaluation - Market Size. 
]]></description>
      <pubDate>Sat, 9 May 2020 02:10:45 +0000</pubDate>
      <author>info@propelx.com (Swati Chaturvedi, Andy Reed)</author>
      <link>https://blog.propelx.com/podcast/</link>
      <enclosure length="21473115" type="audio/mpeg" url="https://cdn.simplecast.com/audio/1698c8/1698c82a-df63-4b69-bd2d-2b9efbf035e7/3f356b59-156a-4c0d-8900-e86cfec80c0b/podcast-6-market-evaluation_tc.mp3?aid=rss_feed&amp;feed=DskUOSmn"/>
      <itunes:title>How to Evaluate the Market for a Startup</itunes:title>
      <itunes:author>Swati Chaturvedi, Andy Reed</itunes:author>
      <itunes:duration>00:22:23</itunes:duration>
      <itunes:summary>In Episode 4 we presented a framework to Evaluate startups. The framework lays out several criteria along which you may evaluate startups. Market size is one of those criteria. 

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.

In this Episode,  Andy and Swati discuss how to understand the Market for a startup. Questions we discuss are:  Why is an understanding of market potential relevant (and what is market potential anyway)? How should one estimate the market size? Does every startup really have to have a humungous market running into many billions of dollars? 

Join us as we discuss these topics and more, that surround the key elements of startup evaluation - Market Size.</itunes:summary>
      <itunes:subtitle>In Episode 4 we presented a framework to Evaluate startups. The framework lays out several criteria along which you may evaluate startups. Market size is one of those criteria. 

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.

In this Episode,  Andy and Swati discuss how to understand the Market for a startup. Questions we discuss are:  Why is an understanding of market potential relevant (and what is market potential anyway)? How should one estimate the market size? Does every startup really have to have a humungous market running into many billions of dollars? 

Join us as we discuss these topics and more, that surround the key elements of startup evaluation - Market Size.</itunes:subtitle>
      <itunes:keywords>market size, market potential, crowdfunding, venture capital, angel investments, angel investor, startup evaulation, due diligence</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>6</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6ce3d9be-dad9-42c4-b7b3-a09a22192f5c</guid>
      <title>The Process of Angel Investing with Kiki Tidwell</title>
      <description><![CDATA[Join us as we interview our guest - Kiki Tidwell - a prolific angel investor, philanthropist, and cleantech evangelist. Among her many activities, Kiki is also a Founding Member of the Tech Advisory Group for the Stanford Center for Human Rights and International Justice. More on Kiki here: https://humanrights.stanford.edu/people/kiki-tidwell

In this episode, we discuss how Kiki invests. Her process - starting from sourcing deal-flow, conducting diligence, evaluating the team and more. Kiki also shares her insights on success and failure and how to build a portfolio.

We must emphasize, as always, that investing in early stage, unproven startups, is a high risk activity. There is no exact science to evaluating these companies. These investments carry the risk of complete capital loss.

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments. 
]]></description>
      <pubDate>Fri, 1 May 2020 18:28:34 +0000</pubDate>
      <author>info@propelx.com (Kiki Tidwell, Swati Chaturvedi)</author>
      <link>https://podcast.propelx.com/episodes/the-process-of-angel-investing-with-kiki-tidwell-qsv7ZlgF</link>
      <enclosure length="21649075" type="audio/mpeg" url="https://cdn.simplecast.com/audio/1698c8/1698c82a-df63-4b69-bd2d-2b9efbf035e7/88ea61b8-6162-463a-8720-d1e8af9364c6/podcast-6-interview-with-kiki_tc.mp3?aid=rss_feed&amp;feed=DskUOSmn"/>
      <itunes:title>The Process of Angel Investing with Kiki Tidwell</itunes:title>
      <itunes:author>Kiki Tidwell, Swati Chaturvedi</itunes:author>
      <itunes:image href="https://image.simplecastcdn.com/images/66d4740c-3ff3-4111-bc8a-c7bce86a48ee/e0f4df1b-0c45-455d-979c-e12d0ddb9d9d/3000x3000/ep-5-podcast-1080x1080.jpg?aid=rss_feed"/>
      <itunes:duration>00:22:34</itunes:duration>
      <itunes:summary>Join us as we interview our guest - Kiki Tidwell - a prolific angel investor, philanthropist, and cleantech evangelist. Among her many activities, Kiki is also a Founding Member of the Tech Advisory Group for the Stanford Center for Human Rights and International Justice. More on Kiki here: https://humanrights.stanford.edu/people/kiki-tidwell

In this episode, we discuss how Kiki invests. Her process - starting from sourcing deal-flow, conducting diligence, evaluating the team and more. Kiki also shares her insights on success and failure and how to build a portfolio.

We must emphasize, as always, that investing in early stage, unproven startups, is a high risk activity. There is no exact science to evaluating these companies. These investments carry the risk of complete capital loss.

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.</itunes:summary>
      <itunes:subtitle>Join us as we interview our guest - Kiki Tidwell - a prolific angel investor, philanthropist, and cleantech evangelist. Among her many activities, Kiki is also a Founding Member of the Tech Advisory Group for the Stanford Center for Human Rights and International Justice. More on Kiki here: https://humanrights.stanford.edu/people/kiki-tidwell

In this episode, we discuss how Kiki invests. Her process - starting from sourcing deal-flow, conducting diligence, evaluating the team and more. Kiki also shares her insights on success and failure and how to build a portfolio.

We must emphasize, as always, that investing in early stage, unproven startups, is a high risk activity. There is no exact science to evaluating these companies. These investments carry the risk of complete capital loss.

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.</itunes:subtitle>
      <itunes:keywords>investors, angel investing, evaluating a startup, crowdfunding, venture capital, alternative investments, angel investors, startups</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>5</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">0759aaa8-337e-4a3e-8a16-b73104db0d57</guid>
      <title>A Framework to Evaluate Startups</title>
      <description><![CDATA[Startup investing is inherently different from investing in the public markets. There is no 10K or 10Q to review, no analyst commentary, no chatter on Seeking Alpha, there aren’t even discounted cash flows. How does one evaluate such a company? 

We discuss in this episode a framework to evaluate startups. We identify eight factors that can be used to evaluate a company: 1) Market risk 2) Competition risk 3) Execution risk (call it team risk) 4) Technology Risk 5) Regulatory risk 6) Financing risk 7) IP risk 8) Exit potential.

We had also published a blog on this topic, that you might want to read: https://blog.propelx.com/conducting-diligence-on-deep-technology-startups/

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments. 
]]></description>
      <pubDate>Sat, 4 Apr 2020 00:32:14 +0000</pubDate>
      <author>info@propelx.com (Swati Chaturvedi, Anderson Reed)</author>
      <link>https://podcast.propelx.com/episodes/a-framework-to-evaluate-startups-UQ0W849P</link>
      <enclosure length="11640625" type="audio/mpeg" url="https://cdn.simplecast.com/audio/1698c8/1698c82a-df63-4b69-bd2d-2b9efbf035e7/4d93214e-9977-42bc-88ba-9e934bb83e9e/episode-four-evaluation-framework_tc.mp3?aid=rss_feed&amp;feed=DskUOSmn"/>
      <itunes:title>A Framework to Evaluate Startups</itunes:title>
      <itunes:author>Swati Chaturvedi, Anderson Reed</itunes:author>
      <itunes:duration>00:12:08</itunes:duration>
      <itunes:summary>Startup investing is inherently different from investing in the public markets. There is no 10K or 10Q to review, no analyst commentary, no chatter on Seeking Alpha, there aren’t even discounted cash flows. How does one evaluate such a company? 

We discuss in this episode a framework to evaluate startups. We identify eight factors that can be used to evaluate a company: 1) Market risk 2) Competition risk 3) Execution risk (call it team risk) 4) Technology Risk 5) Regulatory risk 6) Financing risk 7) IP risk 8) Exit potential.

We had also published a blog on this topic, that you might want to read: https://blog.propelx.com/conducting-diligence-on-deep-technology-startups/

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.</itunes:summary>
      <itunes:subtitle>Startup investing is inherently different from investing in the public markets. There is no 10K or 10Q to review, no analyst commentary, no chatter on Seeking Alpha, there aren’t even discounted cash flows. How does one evaluate such a company? 

We discuss in this episode a framework to evaluate startups. We identify eight factors that can be used to evaluate a company: 1) Market risk 2) Competition risk 3) Execution risk (call it team risk) 4) Technology Risk 5) Regulatory risk 6) Financing risk 7) IP risk 8) Exit potential.

We had also published a blog on this topic, that you might want to read: https://blog.propelx.com/conducting-diligence-on-deep-technology-startups/

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.</itunes:subtitle>
      <itunes:keywords>angel investing, evaluate startup, startup investing, startup diligence, crowdfunding, venture capital, alternative investments, angel investors, dealflow, startups, due diligence</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>4</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">39589d88-b888-468a-9af3-f4578ab76e8a</guid>
      <title>The Process of Investing with Dr. Ronjon Nag</title>
      <description><![CDATA[Learn the process of investing from a seasoned investor - Dr. Ronjon Nag, Director of MIT Alumni Angel Investors of Northern California as well as the Founder and Managing Director of the R42 Group. Dr. Nag is a serial entrepreneur (having sold his companies to Blackberry and Motorola), an active and prolific angel investor, as well as a lecturer in Artificial Intelligence at Stanford University. His newest venture - the R42 Group invests in AI, Science and Biotech, 5G and FinTech. Check it out at R42Group.com

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments. 
]]></description>
      <pubDate>Sat, 14 Mar 2020 03:31:10 +0000</pubDate>
      <author>info@propelx.com (Dr. Ronjon Nag, Swati Chaturvedi)</author>
      <link>https://podcast.propelx.com/episodes/the-process-of-investing-with-dr-ronjon-nag-8M8rtK9D</link>
      <enclosure length="34376768" type="audio/mpeg" url="https://cdn.simplecast.com/audio/1698c8/1698c82a-df63-4b69-bd2d-2b9efbf035e7/59a97809-6506-4990-9f10-c60c580e3826/episode-three-ronjon_tc.mp3?aid=rss_feed&amp;feed=DskUOSmn"/>
      <itunes:title>The Process of Investing with Dr. Ronjon Nag</itunes:title>
      <itunes:author>Dr. Ronjon Nag, Swati Chaturvedi</itunes:author>
      <itunes:image href="https://image.simplecastcdn.com/images/66d4740c-3ff3-4111-bc8a-c7bce86a48ee/4e626009-71a8-4f5e-a852-cf7125886866/3000x3000/ep-3-podcast-1080x1080.jpg?aid=rss_feed"/>
      <itunes:duration>00:35:49</itunes:duration>
      <itunes:summary>Learn the process of investing from a seasoned investor - Dr. Ronjon Nag, Director of MIT Alumni Angel Investors of Northern California as well as the Founder and Managing Director of the R42 Group. Dr. Nag is a serial entrepreneur (having sold his companies to Blackberry and Motorola), an active and prolific angel investor, as well as a lecturer in Artificial Intelligence at Stanford University. His newest venture - the R42 Group invests in AI, Science and Biotech, 5G and FinTech. Check it out at R42Group.com

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.</itunes:summary>
      <itunes:subtitle>Learn the process of investing from a seasoned investor - Dr. Ronjon Nag, Director of MIT Alumni Angel Investors of Northern California as well as the Founder and Managing Director of the R42 Group. Dr. Nag is a serial entrepreneur (having sold his companies to Blackberry and Motorola), an active and prolific angel investor, as well as a lecturer in Artificial Intelligence at Stanford University. His newest venture - the R42 Group invests in AI, Science and Biotech, 5G and FinTech. Check it out at R42Group.com

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.</itunes:subtitle>
      <itunes:keywords>angel investing, startup investing, r42group, crowdfunding, venture capital, alternative investments, angel investors, dealflow, startups</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>3</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">242b2cd9-83a9-4309-a9c2-c934d8c94795</guid>
      <title>Getting Started in Angel Investing</title>
      <description><![CDATA[This episode discusses how you can get started in angel investing - how many companies should you plan to invest in, how many should you evaluate before you make an investment, where to find deal-flow, how to connect with early stage companies and more...

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments. 
]]></description>
      <pubDate>Tue, 3 Mar 2020 23:48:44 +0000</pubDate>
      <author>info@propelx.com (Swati Chaturvedi, Andy Reed)</author>
      <link>https://podcast.propelx.com/episodes/getting-started-in-angel-investing-nRjgWlqW</link>
      <enclosure length="13569088" type="audio/mpeg" url="https://cdn.simplecast.com/audio/1698c8/1698c82a-df63-4b69-bd2d-2b9efbf035e7/c00371f0-5360-4f23-80c8-cda033425861/episode-two-getting-started_tc.mp3?aid=rss_feed&amp;feed=DskUOSmn"/>
      <itunes:title>Getting Started in Angel Investing</itunes:title>
      <itunes:author>Swati Chaturvedi, Andy Reed</itunes:author>
      <itunes:duration>00:14:09</itunes:duration>
      <itunes:summary>This episode discusses how you can get started in angel investing - how many companies should you plan to invest in, how many should you evaluate before you make an investment, where to find deal-flow, how to connect with early stage companies and more...

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.</itunes:summary>
      <itunes:subtitle>This episode discusses how you can get started in angel investing - how many companies should you plan to invest in, how many should you evaluate before you make an investment, where to find deal-flow, how to connect with early stage companies and more...

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.</itunes:subtitle>
      <itunes:keywords>angel investing, startup investing, crowdfunding, venture capital, alternative investments, angel investors, dealflow, startups</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>2</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">5640d121-827f-4796-aeb7-e4e6d599519d</guid>
      <title>Who Should be an Angel Investor?</title>
      <description><![CDATA[<p>Andy Reed interviews Swati Chaturvedi to discuss the topic: Who should be an angel investor? </p><p>Discussions focus on three key criteria as you consider angel investing: </p><ol><li>Are you an accredited investor (in the United States) or permitted by your country's regulations to invest in startups?</li><li>Will you be able to set aside sufficient capital to build a diversified portfolio? Swati suggests a rule of thumb to consider -  invest in 20 or more startups to build a diversified portfolio. Assuming you can set aside a minimum of $5,000 per startup, you should be able to invest at least $100,000 in startups over 3-4 year.</li><li>Are you able to stomach the risk? Andy and Swati discuss startup volatility and high risk nature.</li></ol><p>If you are ready to be angel investor, join us at <a href="https://www.propelx.com/">https://www.propelx.com/</a></p><p>For more on angel investing, follow us at:</p><p><a href="https://www.linkedin.com/company/propel-x-">LinkedIn</a> | <a href="https://twitter.com/propel_x">Twitter</a> | <a href="https://www.facebook.com/propelxinc/">Facebook</a></p>
]]></description>
      <pubDate>Thu, 20 Feb 2020 22:35:16 +0000</pubDate>
      <author>info@propelx.com (Swati Chaturvedi, Andy Reed)</author>
      <link>https://podcast.propelx.com/episodes/who-should-be-an-angel-investor-jFIap_7b</link>
      <content:encoded><![CDATA[<p>Andy Reed interviews Swati Chaturvedi to discuss the topic: Who should be an angel investor? </p><p>Discussions focus on three key criteria as you consider angel investing: </p><ol><li>Are you an accredited investor (in the United States) or permitted by your country's regulations to invest in startups?</li><li>Will you be able to set aside sufficient capital to build a diversified portfolio? Swati suggests a rule of thumb to consider -  invest in 20 or more startups to build a diversified portfolio. Assuming you can set aside a minimum of $5,000 per startup, you should be able to invest at least $100,000 in startups over 3-4 year.</li><li>Are you able to stomach the risk? Andy and Swati discuss startup volatility and high risk nature.</li></ol><p>If you are ready to be angel investor, join us at <a href="https://www.propelx.com/">https://www.propelx.com/</a></p><p>For more on angel investing, follow us at:</p><p><a href="https://www.linkedin.com/company/propel-x-">LinkedIn</a> | <a href="https://twitter.com/propel_x">Twitter</a> | <a href="https://www.facebook.com/propelxinc/">Facebook</a></p>
]]></content:encoded>
      <enclosure length="13760932" type="audio/mpeg" url="https://cdn.simplecast.com/audio/1698c8/1698c82a-df63-4b69-bd2d-2b9efbf035e7/d0f827f8-92aa-4259-9d27-1ea5df3500ab/episode-one_tc.mp3?aid=rss_feed&amp;feed=DskUOSmn"/>
      <itunes:title>Who Should be an Angel Investor?</itunes:title>
      <itunes:author>Swati Chaturvedi, Andy Reed</itunes:author>
      <itunes:duration>00:14:21</itunes:duration>
      <itunes:summary>Considering angel investing? Here are some criteria to consider:
1. Are you permitted by regulations?
2. Will you have sufficient capital to build a diversified portfolio over 3-4 yrs?
3. Can you stomach the (high) risk?

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.</itunes:summary>
      <itunes:subtitle>Considering angel investing? Here are some criteria to consider:
1. Are you permitted by regulations?
2. Will you have sufficient capital to build a diversified portfolio over 3-4 yrs?
3. Can you stomach the (high) risk?

Disclaimer: Propel(x) is a funding platform, not a Broker-Dealer. Securities are offered through Hubble Investments, member FINRA/SIPC and an affiliate of Propel(x). Private investments are highly illiquid and risky and are not suitable for all investors. Past performance is not indicative of future results. You should speak with your financial advisor, accountant, and/or attorney when evaluating private offerings. Neither Propel(x) nor Hubble Investments makes any recommendations or provides advice about investments.</itunes:subtitle>
      <itunes:keywords>angel investing, startup investing, crowdfunding, venture capital, alternative investments, angel investors</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>1</itunes:episode>
    </item>
  </channel>
</rss>